看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 8.5x - 9.3x | 8.9x |
| Selected Fwd EBITDA Multiple | 16.0x - 17.6x | 16.8x |
| Fair Value | €0.74 - €0.90 | €0.82 |
| Upside | -30.9% - -16.0% | -23.4% |
| Benchmarks | Ticker | Full Ticker |
| Crossject Société Anonyme | ALCJ | ENXTPA:ALCJ |
| Implanet S.A. | ALIMP | ENXTPA:ALIMP |
| Amplitude Surgical SA | AMPLI | ENXTPA:AMPLI |
| S.M.A.I.O S.A. | ALSMA | ENXTPA:ALSMA |
| I.CERAM SA | ALICR | ENXTPA:ALICR |
| Diagnostic Medical Systems S.A. | ALDMS | ENXTPA:ALDMS |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| ALCJ | ALIMP | AMPLI | ALSMA | ALICR | ALDMS | ||
| ENXTPA:ALCJ | ENXTPA:ALIMP | ENXTPA:AMPLI | ENXTPA:ALSMA | ENXTPA:ALICR | ENXTPA:ALDMS | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | NM- | NM- | 3.2% | NM- | NM- | NM- | |
| 3Y CAGR | NM- | NM- | 14.3% | NM- | NM- | 47.5% | |
| Latest Twelve Months | 24.5% | -8.6% | 9.4% | -272.8% | NM | 35.6% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | -179.4% | -56.6% | 20.5% | -51.9% | -87.9% | -2.0% | |
| Prior Fiscal Year | -277.7% | -54.9% | 23.2% | -14.0% | -14.0% | 5.9% | |
| Latest Fiscal Year | -197.2% | -47.2% | 22.3% | -51.2% | -127.0% | 7.2% | |
| Latest Twelve Months | -197.2% | -47.2% | 23.0% | -51.2% | -178.3% | 7.2% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 26.28x | 1.83x | 3.64x | 3.58x | 2.17x | 0.78x | |
| EV / LTM EBITDA | -13.3x | -3.9x | 15.8x | -7.0x | -1.2x | 10.8x | |
| EV / LTM EBIT | -8.3x | -3.6x | 29.1x | -6.2x | -1.1x | -48.6x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | -13.3x | -3.9x | 15.8x | ||||
| Historical EV / LTM EBITDA | -20.3x | -4.8x | 10.8x | ||||
| Selected EV / LTM EBITDA | 8.5x | 8.9x | 9.3x | ||||
| (x) LTM EBITDA | 4 | 4 | 4 | ||||
| (=) Implied Enterprise Value | 30 | 31 | 33 | ||||
| (-) Non-shareholder Claims * | (16) | (16) | (16) | ||||
| (=) Equity Value | 14 | 15 | 17 | ||||
| (/) Shares Outstanding | 20.9 | 20.9 | 20.9 | ||||
| Implied Value Range | 0.67 | 0.74 | 0.82 | ||||
| FX Rate: EUR/EUR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 0.67 | 0.74 | 0.82 | 1.07 | |||
| Upside / (Downside) | -37.9% | -30.9% | -23.8% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | ALCJ | ALIMP | AMPLI | ALSMA | ALICR | ALDMS | |
| Enterprise Value | 112 | 17 | 395 | 20 | 2 | 38 | |
| (+) Cash & Short Term Investments | 7 | 2 | 20 | 3 | 0 | 5 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (21) | (6) | (120) | (2) | (2) | (20) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | 0 | (1) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 98 | 13 | 295 | 21 | 0 | 22 | |
| (/) Shares Outstanding | 47.8 | 125.0 | 48.0 | 5.2 | 0.4 | 20.9 | |
| Implied Stock Price | 2.06 | 0.10 | 6.15 | 3.96 | 0.40 | 1.07 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 2.06 | 0.10 | 6.15 | 3.96 | 0.40 | 1.07 | |
| Trading Currency | EUR | EUR | EUR | EUR | EUR | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |